ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 73 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2019. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $241,000 | +123.1% | 72,500 | +140.1% | 0.02% | +183.3% |
| Q1 2019 | $108,000 | -6.9% | 30,200 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $116,000 | -48.9% | 30,200 | +25.6% | 0.01% | -33.3% |
| Q3 2018 | $227,000 | -53.6% | 24,050 | -64.1% | 0.01% | -52.6% |
| Q2 2018 | $489,000 | +34.7% | 66,965 | -7.6% | 0.02% | +58.3% |
| Q1 2018 | $363,000 | -13.4% | 72,500 | -12.7% | 0.01% | 0.0% |
| Q4 2017 | $419,000 | +437.2% | 83,000 | +264.0% | 0.01% | +140.0% |
| Q3 2016 | $78,000 | -25.7% | 22,800 | -24.5% | 0.01% | -37.5% |
| Q2 2016 | $105,000 | – | 30,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 260,000 | $866,000 | 0.34% |
| RTW INVESTMENTS, LP | 5,978,355 | $19,908,000 | 0.31% |
| GSA CAPITAL PARTNERS LLP | 309,839 | $1,032,000 | 0.17% |
| QCM Cayman, Ltd. | 12,728 | $42,000 | 0.13% |
| COWEN AND COMPANY, LLC | 486,717 | $1,621,000 | 0.11% |
| Hudson Bay Capital Management LP | 1,400,000 | $4,662,000 | 0.06% |
| Kerrisdale Advisers, LLC | 208,150 | $693,000 | 0.05% |
| Secure Asset Management, LLC | 10,000 | $33,000 | 0.02% |
| PDT Partners, LLC | 72,500 | $241,000 | 0.02% |
| Point72 Asset Management, L.P. | 1,037,700 | $3,456,000 | 0.02% |